Brief: Mesoblast Posts HY Total Revenues $51.3 Million
27/02/2026 02:03
Feb 27 (Reuters) - Mesoblast Ltd MSB.AX: HY TOTAL REVENUES $51.3 MILLION HY LOSS ATTRIBUTABLE $40.2 MILLION Further company coverage: MSB.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mesoblast
See all newsBrief: Mesoblast William Burns To Retire From Board At 2026 AGM
Brief: Mesoblast Says Q1 Net Revenues Up 44%
Australia's Mesoblast hits one-month high on upbeat quarterly update
Australia's Mesoblast drops as Bell Potter cuts target price after key drug misses sales view
Brief: Mesoblast Says FDA Approves New Potency Assay For Commercial Ryoncil